Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Non-cash Items (2022 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Non-cash Items for 4 consecutive years, with $999882.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items rose 4307.68% year-over-year to $999882.0, compared with a TTM value of $999882.0 through Sep 2025, up 4307.68%, and an annual FY2025 reading of $999882.0, up 4307.68% over the prior year.
  • Non-cash Items was $999882.0 for Q3 2025 at Neuroone Medical Technologies, up from $22685.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $999882.0 in Q3 2025 and bottomed at $20064.0 in Q3 2023.
  • Average Non-cash Items over 4 years is $282981.5, with a median of $55990.0 recorded in 2022.
  • The sharpest move saw Non-cash Items plummeted 77.53% in 2023, then soared 4307.68% in 2025.
  • Year by year, Non-cash Items stood at $89295.0 in 2022, then tumbled by 77.53% to $20064.0 in 2023, then increased by 13.06% to $22685.0 in 2024, then skyrocketed by 4307.68% to $999882.0 in 2025.
  • Business Quant data shows Non-cash Items for NMTC at $999882.0 in Q3 2025, $22685.0 in Q3 2024, and $20064.0 in Q3 2023.